Lakewood-Amedex Biotherapeutics, Inc.
LABT
$2.18
-$0.14-6.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.58M | 11.70K | 236.40K | 658.40K | 1.27M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 256.00K | 38.90K | 69.00K | 119.80K | 52.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.50K | -- | -- | -- | -- |
| Total Current Assets | 4.85M | 50.60K | 305.40K | 778.20K | 1.32M |
|
|
|||||
| Total Current Assets | 4.85M | 50.60K | 305.40K | 778.20K | 1.32M |
| Net Property, Plant & Equipment | 106.90K | 137.60K | 168.10K | 198.40K | 228.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.80K | 8.10K | 8.10K | 8.50K | 8.50K |
| Total Assets | 4.96M | 196.30K | 481.60K | 985.10K | 1.56M |
|
|
|||||
| Total Accounts Payable | 165.90K | 547.80K | 381.00K | 278.80K | 79.50K |
| Total Accrued Expenses | 361.40K | 733.80K | 404.80K | 283.60K | 444.30K |
| Short-term Debt | -- | 1.63M | 1.50M | 1.50M | 1.50M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 101.60K | 121.00K | 119.30K | 117.60K | 115.90K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 628.90K | 3.03M | 2.41M | 2.18M | 2.14M |
|
|
|||||
| Total Current Liabilities | 628.90K | 3.03M | 2.41M | 2.18M | 2.14M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 1.63M | 1.50M | 1.50M | 1.50M |
| Capital Leases | -- | 10.30K | 41.00K | 71.40K | 101.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 628.90K | 3.04M | 2.45M | 2.25M | 2.24M |
|
|
|||||
| Common Stock & APIC | 73.12M | 51.58M | 51.53M | 51.49M | 50.16M |
| Retained Earnings | -68.64M | -54.27M | -53.35M | -52.61M | -50.70M |
| Treasury Stock & Other | -150.00K | -150.00K | -150.00K | -150.00K | -150.00K |
| Total Common Equity | 4.33M | -2.84M | -1.97M | -1.27M | -686.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 100.00 | 3.00K | 3.00K | 3.00K | 3.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 100.00 | 3.00K | 3.00K | 3.00K | 3.00K |
|
|
|||||
| Total Common Equity | 4.33M | -2.84M | -1.97M | -1.27M | -686.30K |
| Total Preferred Equity | 100.00 | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.33M | -2.84M | -1.96M | -1.27M | -683.30K |
|
|
|||||